Nicotine replacement therapy (NRT) is a medically-approved way to take nicotine by means other than tobacco. It is used to help with quitting smoking or stopping chewing tobacco. It increases the chance of quitting smoking by about 50% to 70%.Often it is used along with other behavioral techniques. NRT has also been used to treat ulcerative colitis. Types of NRT include the adhesive patch, chewing gum, lozenges, nose spray, and inhaler. The use of more than one type of NRT at a time may increase effectiveness.

The global Nicotine Replacement Therapy (NRT) Products market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Nicotine Replacement Therapy (NRT) Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nicotine Replacement Therapy (NRT) Products market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Nicotine Replacement Therapy (NRT) Products in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Nicotine Replacement Therapy (NRT) Products manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Cipla
Novartis
GlaxoSmithKline
Takeda
McNeil
Revolymer
Imperial Tobacco
VMR products

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Sprays
Inhalers
Chewing gums
Transdermal patches
Lozenges
Sublingual tablets

Segment by Application
Home
Hospital